Details for 2018782185

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR AUSWAHL EINER BEHANDLUNG FÜR KREBSPATIENTEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018782185

EP Publication Number

3676404

E-Number

1833135

Language

PCT Number

IB18056318

Publication Date

08.07.2020 A

03.09.2025 B1

Registration Date

03.09.2025

AT Publication Date

15.09.2025

Application Date

21.08.2018

Registration Number

Priorities

31.08.2017

201762552842 P

IPC

C12Q 1/6886 20180101AFI20241111BHEP

Maximum Duration of Protection

21.08.2038

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

SU, Feic/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

GERMA, Marie-Carolinec/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

MILLER, Michellec/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936US

HE, Weic/o Novartis Institutes for Biomedical Research Inc. 220 Massachusetts Avenue Cambridge, Massachusetts 02139US